NEW YORK (GenomeWeb) – The Gene Editing Institute of the Helen F. Graham Cancer Center has signed an agreement to provide gene editing services and genetically modified cell lines to Analytical Biological Services (ABS), the partners announced today.

Under the terms of the three-year deal, the Gene Editing Institute will be the sole provider of gene editing services and genetically modified cell lines to ABS for replication, marketing, and distribution to pharmaceutical and biomedical research companies worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.